116 related articles for article (PubMed ID: 36201657)
1. Diabetes Affects Antibody Response to SARS-CoV-2 Vaccination in Older Residents of Long-term Care Facilities: Data From the GeroCovid Vax Study.
Virgilio E; Trevisan C; Abbatecola A; Malara A; Palmieri A; Fedele G; Stefanelli P; Leone P; Schiavoni I; Maggi S; Volpato S; Antonelli Incalzi R; Onder G;
Diabetes Care; 2022 Dec; 45(12):2935-2942. PubMed ID: 36201657
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study.
Trevisan C; Raparelli V; Malara A; Abbatecola AM; Noale M; Palmieri A; Fedele G; Di Lonardo A; Leone P; Schiavoni I; Stefanelli P; Volpato S; Antonelli Incalzi R; Onder G;
Intern Emerg Med; 2023 Aug; 18(5):1337-1347. PubMed ID: 37120663
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: The GeroCovid Vax Study.
Trevisan C; Haxhiaj L; Malara A; Abbatecola A; Fedele G; Palmieri A; Leone P; Schiavoni I; Stefanelli P; Maggi S; Sergi G; Volpato S; Incalzi RA; Onder G;
Drugs Aging; 2023 Dec; 40(12):1133-1141. PubMed ID: 37938521
[TBL] [Abstract][Full Text] [Related]
4. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
[TBL] [Abstract][Full Text] [Related]
5. Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study.
Tut G; Lancaster T; Sylla P; Butler MS; Kaur N; Spalkova E; Bentley C; Amin U; Jadir A; Hulme S; Ayodele M; Bone D; Tut E; Bruton R; Krutikov M; Giddings R; Shrotri M; Azmi B; Fuller C; Baynton V; Irwin-Singer A; Hayward A; Copas A; Shallcross L; Moss P
Lancet Healthy Longev; 2022 Jul; 3(7):e461-e469. PubMed ID: 35813280
[TBL] [Abstract][Full Text] [Related]
6. Sero-survey on long-term care facility residents reveals increased risk of sub-optimal antibody response to BNT162b2: implications for breakthrough prevention.
Caimi B; Franzetti M; Velleca R; Lai A; Gatti A; Rossi PL; D'Orso M; Pregliasco F; Balotta C; Calicchio G
BMC Geriatr; 2022 Mar; 22(1):191. PubMed ID: 35272615
[TBL] [Abstract][Full Text] [Related]
7. Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities.
Trigueros M; Pradenas E; Palacín D; Muñoz-López F; Ávila-Nieto C; Trinité B; Bonet-Simó JM; Isnard M; Moreno N; Marfil S; Rovirosa C; Puig T; Grau E; Chamorro A; Martinez A; Toledo R; Font M; Ara J; Carrillo J; Mateu L; Blanco J; Clotet B; Prat N; Massanella M;
Age Ageing; 2022 May; 51(5):. PubMed ID: 35595256
[TBL] [Abstract][Full Text] [Related]
8. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
[TBL] [Abstract][Full Text] [Related]
9. Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home Cohort.
Smoot K; Yang J; Tacker DH; Welch S; Khodaverdi M; Kimble W; Wen S; Amjad A; Marsh C; Perrotta PL; Hodder S
JAMA Netw Open; 2022 Sep; 5(9):e2231334. PubMed ID: 36098966
[TBL] [Abstract][Full Text] [Related]
10. Antibody response after COVID-19 vaccination in intravenous immunoglobulin-treated immune neuropathies.
Svačina MKR; Meißner A; Schweitzer F; Ladwig A; Sprenger-Svačina A; Klein I; Wüstenberg H; Kohle F; Schneider C; Grether NB; Wunderlich G; Fink GR; Klein F; Di Cristanziano V; Lehmann HC
Eur J Neurol; 2022 Nov; 29(11):3380-3388. PubMed ID: 35842740
[TBL] [Abstract][Full Text] [Related]
11. Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19-Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 2021.
Muhsen K; Maimon N; Mizrahi AY; Varticovschi B; Bodenheimer O; Cohen D; Dagan R
JAMA Netw Open; 2022 Jul; 5(7):e2219940. PubMed ID: 35796153
[TBL] [Abstract][Full Text] [Related]
12. Impact of Prior Infection on SARS-CoV-2 Antibody Responses in Vaccinated Long-Term Care Facility Staff.
Gallichotte EN; Nehring M; Stromberg S; Young MC; Snell A; Daniels J; Pabilonia KL; VandeWoude S; Ehrhart N; Ebel GD
mSphere; 2022 Aug; 7(4):e0016922. PubMed ID: 35862798
[TBL] [Abstract][Full Text] [Related]
13. Antibody Response 3 Months after 2 Doses of BNT162b2 mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities.
Causa R; Almagro-Nievas D; Rivera-Izquierdo M; Benítez-Muñoz N; López-Hernández B; García-García F; Alvarez-Estévez M; Soto-Pérez MO; Bermúdez-Tamayo C
Gerontology; 2022; 68(8):910-916. PubMed ID: 34758461
[TBL] [Abstract][Full Text] [Related]
14. Anti-nucleocapsid antibody levels following initial and repeat SARS-CoV-2 infections in a cohort of long-term care facility residents in England (VIVALDI).
Stirrup O; Tut G; Krutikov M; Bone D; Lancaster T; Azmi B; Monakhov I; Moss P; Hayward A; Copas A; Shallcross L
Wellcome Open Res; 2024; 9():45. PubMed ID: 38818129
[TBL] [Abstract][Full Text] [Related]
15. [Humoral Immune Response in Inactivated SARS-CoV-2 Vaccine: When Should a Booster Dose be Administered?].
Kara E; Tanır F; Demirhindi H; Mete B; Kibar F; Çetiner S; Candevir A; İnaltekin A
Mikrobiyol Bul; 2022 Jul; 56(3):566-573. PubMed ID: 35960246
[TBL] [Abstract][Full Text] [Related]
16. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity after 6 months of BNT162b2 vaccination in frail or disabled nursing home residents: The COVID-A Study.
Salmerón Ríos S; Cortés Zamora EB; Avendaño Céspedes A; Romero Rizos L; Sánchez-Jurado PM; Sánchez-Nievas G; Mas Romero M; Tabernero Sahuquillo MT; Blas Señalada JJ; Murillo Romero A; García Nogueras I; Estrella Cazalla JD; Andrés-Pretel F; Lauschke VM; Stebbing J; Abizanda P
J Am Geriatr Soc; 2022 Mar; 70(3):650-658. PubMed ID: 34894403
[TBL] [Abstract][Full Text] [Related]
18. Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening.
Nace DA; Kip KE; Mellors JW; Peck Palmer OM; Shurin MR; Mulvey K; Crandall M; Sobolewski MD; Enick PN; McCormick KD; Jacobs JL; Kane AL; Lukanski A; Kip PL; Wells A
J Am Med Dir Assoc; 2021 Aug; 22(8):1593-1598. PubMed ID: 34129831
[TBL] [Abstract][Full Text] [Related]
19. Decreasing neutralization antibody levels following vaccination against SARS-CoV-2 in the elderly: an observational study in Southern Moravia, Czech Republic.
Mravčík V; Husa P; Kumpanová Valachovičová S; Vobořil J
Epidemiol Mikrobiol Imunol; 2022; 71(1):9-20. PubMed ID: 35477266
[TBL] [Abstract][Full Text] [Related]
20. Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study.
Shrotri M; Krutikov M; Nacer-Laidi H; Azmi B; Palmer T; Giddings R; Fuller C; Irwin-Singer A; Baynton V; Tut G; Moss P; Hayward A; Copas A; Shallcross L
Lancet Healthy Longev; 2022 Jul; 3(7):e470-e480. PubMed ID: 35813279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
